AstraZeneca PLC (AZN)

AZN (NYSE:Drugs) EQUITY
$31.31
pos +0.00
+0.00%
Today's Range: 31.11 - 31.38 | AZN Avg Daily Volume: 5,867,400
Last Update: 03/24/17 - 4:02 PM EDT
Volume: 0
YTD Performance: 14.60%
Open: $0.00
Previous Close: $31.30
52 Week Range: $25.55 - $35.04
Oustanding Shares: 2,530,458,848
Market Cap: 79,203,361,942
6-Month Chart
TheStreet Ratings Grade for AZN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.50 1.50 1.50 2.00
Latest Dividend: 0.93
Latest Dividend Yield: 4.38%
Dividend Ex-Date: 02/15/17
Price Earnings Ratio: 14.04
Price Earnings Comparisons:
AZN Sector Avg. S&P 500
14.04 22.70 30.30
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.65% 11.82% -2.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.90 -0.10 -0.04
Net Income 20.50 0.30 0.10
EPS 23.80 0.40 0.11
Earnings for AZN:
EBITDA 5.52B
Revenue 23.00B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $0.32 $0.42 $1.79 $1.85
Number of Analysts 1 1 2 3
High Estimate $0.32 $0.42 $1.83 $2.00
Low Estimate $0.32 $0.42 $1.75 $1.57
Prior Year $0.95 $0.83 $4.31 $1.79
Growth Rate (Year over Year) -66.32% -49.40% -58.47% 3.17%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Why the name is sagging, and what it will take to spur the sector higher.
Most of the 10 best stocks of the bull market did it their way.
The old saying that volume precedes price could be playing out
There are nearly too many surging sectors to count.

Biotech Buoyed by Deal Talk Real Money Pro($)

M&A activity is in a serious upswing, and here are some names to watch.
These companies show signs of a change of direction.
Bullish
Dec 09, 2016 | 7:28 AM EST
AZN was upgraded from Market Perform to Outperform, Leerink Partners said. $34 price target. Pullback has created a buying opportunity ...
Stocks in the health care sector seem to have no underpinnings whatsoever.

Columnist Conversations

SPX weekly View Chart »  View in New Window » $SPX Daily

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.